FRONTEO’s AI review tool “KIBIT Automator” is used for legal investigation and litigation cases in an US asset management company
August 4, 2021FRONTEO Adopts Microsoft Azure to Improve Operational Efficiency in the Legal Tech AI Space in the U.S.
November 2, 2021
FRONTEO USA launched a new website on its Life Science business, which is drawing attention.
Under the title of “Equal Medical Care for Everybody with AI”, we introduce our AI system powered by “Concept Encoder”, the natural language analysis specialized in the Life Science fields below.
- Conversational dementia diagnosis supported by AI program
- Treatise search AI ”Amanogawa”
- Automatic classification/examination AI “Mekiki”
- Fall prediction AI system”Coroban”
- Drug discovery support AI ”Cascade Eye”
- Text review AI “Guideline Viewer”
FRONTEO USA believes in the growth of people and technology. We will continue to contribute to society in the field of AI × Natural Language.
Life Science Website
https://lifescience.fronteousa.com/
FRONTEO USAは、社会的にも注目を集めるライフサイエンス事業のページを開設いたしました。
「AIですべての人に等しい医療を」を表題に掲げ、ライフサイエンス領域に特化した自然言語解析AI「Concept Encoder」を活用した製品を紹介しております。
- 会話型 認知症診断支援AIプログラム
- 論文探索AI「Amanogawa」
- 自動分類・審査AI「Mekiki」
- 転倒転落予測AIシステム「Coroban」
- 創薬支援AI「Cascade Eye」
- テキスト審査AI「Guideline Viewer」
FRONTEOは人とテクノロジーの成長を信じ、今後もAI×自然言語という分野で社会貢献を続けて参ります。
Do you have questions? We have answers.
FRONTEO eDiscovery experts are standing by to answer your questions about Artificial Intelligence and more.